INSULIN LISPRO WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IS SAFE AND EFFECTIVE IN PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CROSSOVER TRIAL OF INSULIN LISPRO VERSUS INSULIN ASPART

Thrasher James; Bhargava Anuj; Rees Tina M.; Wang Tao; Guzman Cristina B.; Glass Leonard C.

首页> 外文期刊>Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists >INSULIN LISPRO WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IS SAFE AND EFFECTIVE IN PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CROSSOVER TRIAL OF INSULIN LISPRO VERSUS INSULIN ASPART

【24h】

INSULIN LISPRO WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IS SAFE AND EFFECTIVE IN PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CROSSOVER TRIAL OF INSULIN LISPRO VERSUS INSULIN ASPART

机译：连续皮下注射胰岛素的胰岛素替代品在2型糖尿病患者中是安全有效的：胰岛素替代品与胰岛素ASPART的随机交叉试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: This study provides clinical information regarding the use of insulin lispro versus insulin aspart in continuous subcutaneous insulin infusion (CSII) in adult patients with type 2 diabetes mellitus (T2D).

机译：目的：本研究提供有关成人2型糖尿病（T2D）患者使用赖脯胰岛素和门冬胰岛素进行连续皮下胰岛素输注（CSII）的临床信息。

著录项

来源
《Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists》 |2015年第3期|共11页
作者
Thrasher James; Bhargava Anuj; Rees Tina M.; Wang Tao; Guzman Cristina B.; Glass Leonard C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. INSULIN LISPRO WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IS SAFE AND EFFECTIVE IN PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CROSSOVER TRIAL OF INSULIN LISPRO VERSUS INSULIN ASPART [J] . Thrasher James, Bhargava Anuj, Rees Tina M., Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists . 2015,第3期

机译：连续皮下注射胰岛素的胰岛素替代品在2型糖尿病患者中是安全有效的：胰岛素替代品与胰岛素ASPART的随机交叉试验
2. Letter written in response to van bon et Al.: "Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial". [J] . Anonymous Diabetes technology & therapeutics . 2011,第8期

机译：为回应van bon等人而写的信：“在1型糖尿病患者中，相比于门冬胰岛素和通过连续皮下注射胰岛素给予赖脯胰岛素的胰岛素，谷胱甘肽：一项随机对照试验”。
3. A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes. [J] . Weinzimer SA, Ternand C, Howard C, Diabetes care . 2008,第2期

机译：一项随机试验比较了儿童和青少年1型糖尿病患者连续皮下注射门冬胰岛素和赖脯胰岛素的情况。
4. Nano Flow LC-MS Analyses of Insulin Receptor Site-specific Phosphorylation Induced by Insulin Lispro and Basal Insulin Peglispro [C] . Zhongping Liao, Mark W. Farmen, Jason X. Tang, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：纳米流动LC-MS分析胰岛素LISPRO诱导的胰岛素受体特异性磷酸化磷酸化，基础胰岛素PEGLISPRO
5. Evaluating Hypoglycemic Risk of Two Basal Insulin Delivery Methods for Type 1 Diabetes: A Comparison of Tresiba Insulin Against Continuous Subcutaneous Insulin Infusion Using Data from Continuous Glucose Monitors [D] . Lane, Benjamin. 2020

机译：评估1型糖尿病两种基础胰岛素递送方法的低血糖风险：使用来自连续葡萄糖监测器的数据进行TRESIBA胰岛素对连续皮下胰岛素输注的比较
6. Letter Written in Response to van Bon et al.: Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial [O] . Lois Jovanovič -1

机译：回应van Bon等人的信：在1型糖尿病患者中通过连续皮下注射胰岛素与门冬胰岛素和赖斯普胰岛素进行比较的谷氨酰胺：随机对照试验
7. Letter Written in Response to van Bon et al.: “Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial” [O] . Jovanovič, Lois 2011

机译：回应van Bon等人的信：“在1型糖尿病患者中通过连续皮下注射胰岛素与门冬胰岛素和赖斯普胰岛素进行比较的谷氨酰胺：随机对照试验”

INSULIN LISPRO WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IS SAFE AND EFFECTIVE IN PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CROSSOVER TRIAL OF INSULIN LISPRO VERSUS INSULIN ASPART

摘要

著录项

相似文献

相关主题

期刊订阅